|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's Range||114.63 - 119.59|
|52 Week Range||34.41 - 128.23|
|Beta (5Y Monthly)||0.91|
|PE Ratio (TTM)||975.17|
|Earnings Date||May 04, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||119.00|
STAAR Surgical (NASDAQ: STAA) has been a top-performing healthcare stock over the past year, with a mouth-watering return of 244%, compared to a 48% rise in the S&P 500 over the same period. Right now, STAAR Surgical is prohibitively expensive at 33 times revenue and 991 times earnings. In 1993, STAAR Surgical invented the Implantable Collamer Lens (ICL) for treating nearsightedness and gradual loss of vision due to old age.
On that note, the best healthcare stocks for long-term investing have one thing in common, no matter how obscure they might be to the public: Their business models never go out of style, and they probably never will. Molina Healthcare (NYSE: MOH) is an insurance provider that specializes in the low-income segment of the market. Molina's largest customer segment is Medicaid, which accounts for 78% of its revenue.
If you're considering investing your family's stimulus funds in the stock market, it's paramount to be responsible. It's key to look for stocks that have an evergreen business model and a long history of successful execution, rather than tempting targets like hot-shot penny stocks or speculation plays. As its name somewhat implies, STAAR Surgical (NASDAQ: STAA) makes surgically implantable lenses for ophthalmology that correct a variety of ocular issues ranging from nearsightedness to astigmatism.